Actively Recruiting

Age: 65Years +
All Genders
NCT05273125

MOBility Disorders Assessment in Patients With Mild COGnitive Disorders

Led by University Hospital, Lille · Updated on 2025-12-26

417

Participants Needed

2

Research Sites

207 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Mild cognitive impairment (MCI) is defined by lower performance in one or more cognitive domains with preservation of independence in functional abilities. Sixteen percent of community-dwelling older people (over 65 years) live with MCI. They are both cognitively and physically vulnerable. From a cognitive perspective, they are susceptible to converting to the dementia stage at an annual rate of 10%. From a physical perspective, the proportion of slow gait or neurological gait abnormalities can reach 46% in the population with MCI. Falls in turn increase the risk of accelerated cognitive decline and the risk of institutionalization. In the absence of a curative treatment for dementia, it is essential to have an effective and personalized prevention strategy by identifying the predictive factors for falls in this at-risk population with MCI. The research goals of this project are 1) to identify specific predictors for falls in clinic attendees with MCI in preparation for a definitive, fully powered study across France, and 2) to demonstrate the feasibility of a pragmatic fall risk assessment in MCs, whatever its setting and location. We aim to prospectively follow-up people diagnosed with MCI and aged above 65 years old in four MCs in France (three in the North (one community-based MC), and one in the Centre) for one year.

CONDITIONS

Official Title

MOBility Disorders Assessment in Patients With Mild COGnitive Disorders

Who Can Participate

Age: 65Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient being diagnosed with MCI, according to the 2011 criteria
  • Able to walk 4 meters with or without technical assistance
  • Comprehension of French language allowing the realization of the neuropsychological assessment
Not Eligible

You will not qualify if you...

  • Severe visual or hearing impairment that does not allow the assessment
  • Severe pathology that makes follow-up impossible
  • Administrative reasons: inability to receive informed information, inability to participate in the entire study, lack of social security insurance, refusal to sign consent form
  • Under legal protection (guardianship, curatorship, safeguard of justice)

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Les Bateliers Chu Lille

Lille, France, 59037

Actively Recruiting

2

Hop Salengro - Hopital B

Lille, France

Actively Recruiting

Loading map...

Research Team

Y

Yaohua CHEN, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here